Sordarins: In Vitro Activities of New Antifungal Derivatives against Pathogenic Yeasts, <i>Pneumocystis carinii</i> , and Filamentous FungiEsperanza Herreros, Domingo Gargallo‐Viola, M. S. Marriott et al.|Antimicrobial Agents and Chemotherapy|1998Cited by 88
Correlation between In Vitro and In Vivo Activities of GM 237354, a New Sordarin Derivative, against <i>Candida albicans</i> in an In Vitro Pharmacokinetic-Pharmacodynamic Model and Influence of Protein BindingP. Aviles, Domingo Gargallo‐Viola, Christine Falcoz et al.|Antimicrobial Agents and Chemotherapy|2001Cited by 14
Animal Pharmacokinetics and Interspecies Scaling of Sordarin Derivatives following Intravenous AdministrationP. Aviles, Domingo Gargallo‐Viola, Anthony J. Pateman et al.|Antimicrobial Agents and Chemotherapy|2001Cited by 11